CEO and Chairman of Emmaus Life Sciences, Dr. Yutaka Niihara, discusses expanding the application of pharmaceutical-grade L-glutamine (PGLG) as a therapeutic for sickle cell disease to investigating its potential in treating type II diabetes. Emmaus is set to conduct a clinical study in collaboration with the Straub Medical Center to explore the role of PGLG in […]